Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer (NCT07373782) | Clinical Trial Compass
RecruitingPhase 2/3
Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer
Belgium53 participantsStarted 2025-02-11
Plain-language summary
This study is a prospective, non-randomized clinical study aimed at investigating the potential benefits of continuous positive airway pressure (CPAP) support during radiotherapy for breast cancer. CPAP is a device commonly used to support breathing, for example in patients with sleep apnea. The investigators expect a reduction in radiation doses to the heart and/or lungs with CPAP-supported radiotherapy compared to standard radiotherapy (without CPAP), which may also lead to a decrease in radiation-induced heart and/or lung conditions in the long term. The study will also examine how the use of a CPAP device can be implemented in daily radiotherapy practice.
Who can participate
Age range40 Years – 80 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
✓. At least 40 years of age and 80 years or younger at the time of signing the Informed Consent Form (ICF)
✓. Female patients
✓. Patients that underwent breast conserving surgery (BCS)
✓. Left-sided invasive BC / in situ carcinoma with indication for adjuvant RT (\<70 years old)
✓. Left-sided invasive BC with indication for adjuvant locoregional RT (including RT of the regional lymph nodes) (70-80 years old)
✓. Right-sided invasive BC with indication for adjuvant locoregional RT (including RT of the regional lymph nodes)
✓. Prior chemotherapy allowed
Exclusion criteria
✕. Patient has active bullous lung disease, bypassed upper airway, pneumothorax, cerebral spinal fluid leaks, abnormalities of the cribriform plate (contra-indications for the use of CPAP)
What they're measuring
1
Mean heart dose
Timeframe: From enrollment to the end of treatment at +/-8 weeks
✕. Patient has history of major head trauma and/or pneumocephalus (contra-indications for the use of CPAP)
✕. Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP.
✕. Female who is pregnant, breast-feeding or intends to become pregnant (which is a contra-indication for RT in general)
✕. Male BC patients
✕. Patients that underwent mastectomy Patients whose initial tumor was located just beneath the skin (defined as being less than 28mm below the breast surface), indicating the need for an electron boost
✕. Patients requiring RT boost on positive lymph nodes